A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...

Sleep Apnea Treatment Clash: Doctors prefer CPAP, but obese patients lean towards Zepbound. Explore this growing healthcare debate. MONDAY, June 9, 2025 (HealthDay News) — A clash is brewing between ...

But patients with obesity would rather use Zepbound to ease their apnea ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with provid ...

Dr. Cissy Kityo Mutuluuza is a physician, epidemiologist, medical researcher, and the executive director of the Joint ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main ... obstructive sleep apnoea, or cardiovascular disease, but without diabetes.